Concepedia

Johannes Schwenck

JS

Statistics

Publications

23

Citations

956

H-Index

17

Active since

2014

Affiliations

University of Tübingen(Current)

Siemens (Germany)

German Cancer Research Center

Heidelberg University

University Children's Hospital Tübingen

Johannes Schwenck is an author at University of Tübingen specializing in medicine, nuclear medicine, and oncology.

ORCID

Publications per year

2014–2024

23

Publications

23

Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT

Johannes Schwenck, Hansjoerg Rempp, Gerald Reischl et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 276 citations

, , +14

A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila et al. · Cell Metabolism · 2024 · 100 citations · Full text

, , +17

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

Hans-Georg Rammensee, Karl-Heinz Wiesmüller, P. Anoop Chandran et al. · Journal for ImmunoTherapy of Cancer · 2019 · 72 citations · Full text

, , +17

Preclinical and Translational PET/MR Imaging

Hans F. Wehrl, Stefan Wiehr, Mathew R. Divine et al. · Journal of Nuclear Medicine · 2014 · 66 citations · Full text

, , +17

Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive <i>in vivo</i> <sup>18</sup>F-FDG-PET

Johannes Schwenck, Barbara F. Schörg, Francesco Fiz et al. · Theranostics · 2019 · 62 citations · Full text

, , +17

1–5 of 23